Right in the stomach

Helicobacter creates immune system blind spot

Around 50% of people are infected with the gastric bacterium H. pylori, which can lead to gastric cancer. It usually persists life-long, despite a strong inflammatory defence reaction in the gastric mucosa.

Source: MPI for Infection Biology

Persistence in the midst of acute inflammation is a highly unusual feat for a pathogen and the mechanism has so far remained elusive. Now researchers at the Max Planck Institute for Infection Biology in Berlin have shown that by extracting cholesterol from host cell membranes H. pylori prevents assembly of interferon receptors. Without this signalling pathway, the adaptive immune system cannot be summoned to infected cells, generating a “micro-niche” where the bacteria can survive.

Photo
Surface of a Helicobacter-infected mucosoid culture made of normal epithelial cells from the human stomach. Red: Helicobacter pylori, blue: nuclei, green: cell membranes.
Source: MPI for Infection Biology

While gastritis and gastric ulcer disease used to be put down to stress and dietary factors, it was discovered in the 1980s that the actual culprit is infection with a bacterium, H. pylori. This pathogen is now classed as a type I carcinogen by the WHO, as it is the major risk factor for development of gastric carcinoma. Attempts to develop a vaccine against H. pylori have been unsuccessful and the new results provide the first potential explanation for these failures: H. pylori blocks the signal that would allow infected cells to summon help from the immune system.

Driven by their interest in understanding the mechanisms by which bacterial infections can give rise to cancer, the laboratory of Prof. Thomas F. Meyer already discovered over a decade ago that H. pylori expresses an enzyme called cholesterol-α-glucosyltransferase to extract the cholesterol it needs from host cells. Without this enzyme, the bacteria are unable to infect mice. At the time, the group also noted that excess cholesterol in the diet of the mice enhanced clearance of the pathogen but exacerbated inflammation. Exactly how the ability to extract cholesterol was linked to immune evasion remained unclear at the time.

Infected cells are incapable of responding to the cytokines interferon-γ...
Infected cells are incapable of responding to the cytokines interferon-γ (IFN-γ) and IL-22. As a result, inflammation and defense only occur outside the infected niches of the mucosal surface.
Source: MPI for Infection Biology

Showing how H. pylori persists in the midst of an acute inflammation explains a whole series of observations that have puzzled researchers for decades

Pau Morey

Now, new technologies for growing primary stomach cells in vitro have been instrumental for solving this puzzle. Meyer’s laboratory succeeded in reconstituting the mucosal epithelium of the stomach, yielding so-called “mucosoids” in which gastric cells grow as monolayers with an outer and an inner surface and even produce the mucus that lines and protects the stomach. As a result, the infected “mini-organs” could be kept alive for months.

Infected gastric epithelial cells normally summon immune cells and generate antimicrobial factors that kill the bacteria. This response depends on a crucial immune signaling factor produced by epithelial cells: interferon-γ. Using the mucosoid model, the group found that the bacteria survive as small micro-colonies on top of cells. This turned out to be due to the absence of so-called “lipid rafts” in the cell membranes, which are required for assembly of interferon receptor complexes. Without these, host cells simply did not respond to interferon-γ at all. The lipid rafts are made of cholesterol, and their destruction is mediated by the bacterium’s cholesterol-α-glucosyltransferase.

“Showing how H. pylori persists in the midst of an acute inflammation explains a whole series of observations that have puzzled researchers for decades and has caused us to think of the infection scenario in an entirely new light” says Dr. Pau Morey, first author of the study. Dr. Francesco Boccellato, who developed the new in vitro model adds: “the mucosoids enable long-term, stable infections to be investigated – and will be an invaluable tool for examining the mechanisms underlying mucosal infections, the mucosal defence and the emergence of cancer.”


Source: Max-Planck-Institut für Infektionsbiologie

15.03.2018

Read all latest stories

Related articles

Stealthy survivors

Tracing the evolution of E. coli

Bacteria are stealthy organisms. They can multiply in minutes and evolve to survive what we throw at them—including antibiotics. The World Health Organization calls antibiotic resistance “one of…

E. coli

Using harmless bacteria to fight cancer

Several bacterial species have pledged promise in fighting tumors. However, most of them are pathogens. In order to use them as a weapon against cancer and other diseases in humans, researchers must…

T cell response

Scientists find out what makes people survive Ebola

Scientists conducting the first comprehensive study of key immune system cells—collected from West African Ebola survivors— have made a surprising discovery that provides important clues to…

Related products

Infectious diseases testing

Atlas Genetics - Atlas Genetics io system

Atlas Genetics Ltd

Immunochemistry

Beckman Coulter - Anti-Mullerian Hormone (AMH)

Beckman Coulter, Inc.

Immunochemistry

Beckman Coulter - phi (Prostate Health Index)

Beckman Coulter, Inc.

Clinical chemistry

DiaSys Diagnostic Systems - BioMajesty JCA-BM6010/C

DiaSys Diagnostic Systems GmbH

Clinical chemistry

DiaSys Diagnostic Systems - respons910

DiaSys Diagnostic Systems GmbH